āĻšā§āĻŽMSB âĸ ASX
add
Mesoblast Ltd
ā§§.ā§ā§¯$
⧍ā§Ē āĻāĻĒā§āϰāĻŋ, ā§:ā§Ļā§Ļ:ā§Ļā§Ļ PM GMT +ā§§ā§Ļ · AUD · ASX · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§§.ā§ā§Ļ$
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§§.ā§ā§¨$ - ā§§.ā§Žā§§$
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§Ļ.ā§Žā§Ž$ - ā§Š.ā§Šā§$
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§¨ā§¨ā§Ž.ā§ā§¨Â āĻā§ AUD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§ā§Ļ.ā§ā§Ļ āϞāĻž
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
ASX
āĻŦāĻžāĻāĻžāϰ āϏāĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(USD) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ēinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§§ā§Ģ.ā§ā§ŽÂ āϞāĻž | -ā§Ŧ.ā§Žā§Ģ% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§§.ā§Ēā§ŽÂ āĻā§ | ā§Šā§Ē.⧍ā§Ģ% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | -⧍.ā§Ēā§Ļ āĻā§ | -ā§Ēā§.ā§Šā§§% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | -ā§§.ā§Ģā§¨Â āĻšāĻž | -ā§Ģā§Ž.ā§§ā§Ē% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | â | â |
EBITDA | -⧝ā§Ē.ā§Ģā§Ē āϞāĻž | ⧍ā§Ŧ.ā§Ļ⧍% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | -ā§Ļ.ā§Ēā§Ē% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(USD) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ēinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§Š.ā§Žā§Ļ āĻā§ | -ā§Ģā§Ļ.⧝ā§Ŧ% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§Ŧā§Ģ.ā§Šā§ŠÂ āĻā§ | -⧍.ā§Ģā§Š% |
āĻŽā§āĻ āĻĻāĻžā§ | ⧧⧝.ā§¨ā§§Â āĻā§ | ā§§ā§Ž.ā§Žā§Ž% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Ēā§Ŧ.ā§§ā§ŠÂ āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§§ā§§ā§Ģ.⧍ā§Ē āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§Ē.⧍ā§Ģ | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | -ā§Š.ā§Žā§¨% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | -ā§Ē.⧍ā§Ģ% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(USD) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ēinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | -⧍.ā§Ēā§Ļ āĻā§ | -ā§Ēā§.ā§Šā§§% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | -ā§§.ā§Ļā§ŠÂ āĻā§ | ⧍⧍.⧍ā§% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | ā§Š.ā§§ā§Ē āϞāĻž | ā§Žā§§ā§¨.ā§Ģā§Ļ% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -⧍⧧.ā§Šā§¨Â āϞāĻž | -ā§§ā§§ā§Š.ā§Ē⧝% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | -ā§§.⧍ā§Ģ āĻā§ | -ā§Ē⧝⧝.ā§ā§¯% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| -⧝.ā§Ģā§Ģ āϞāĻž | ā§Žā§¯.ā§ā§§% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
⧍ā§Ļā§Ļā§Ē
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§ā§Š